GET A QUOTE

Oxidized High-Density Lipoprotein (OxHDL): From Molecular Modifications to Pathophysiological Implications in Cardiovascular Disease

Molecular Structure and Oxidative Modifications

The process of OxHDL formation entails changes made to HDL particles, through oxidative reactions. During this process of oxidation within HDL particles primarily targets apolipoprotein A-I (apoA-I) the protein in HDL structure. This results in modifications occurring at methionine, tryptophan in and tyrosine residues within apo A-I. This can lead to alterations such, as protein cross-linkage, damage fragmentation and structural shifts that affect function. Moreover, the lipid elements found in HDL e.g. phospholipids and cholesteryl esters undergo peroxidation result in the creation of oxidized varieties including hydroperoxides, cinnamaldehydes and ketones. Cutting edge analytical methods, like mass spectrometry and immune based approaches have made it possible to thoroughly study these alterations and the unique identifiers associated with them.

Formation and Mechanisms of HDL Oxidation

Multiple pathways contribute to the oxidation of HDL through non-enzymatic processes. The myeloperoxidase system is vital, in targeting apoA-I for oxidation in sites during inflammatory states by producing hypochlorous acid and other reactive substances that alter certain amino acid residues. Another notable mechanism of HDL modification involves metal ion catalyzed oxidation with copper and iron as key players. Environmental factors, like smoking pollution and dietary factors can expedite the oxidation of HDL The procedure is impacted by markers of stress and can be adjusted by the antioxidant mechanisms found in the bloodstream.

Functional Consequences and Biological Effects

Oxidative modifications significantly impair HDL’s atheroprotective functions. The cholesterol efflux capacity, HDL’s primary antiatherogenic function, is markedly reduced due to structural changes in apoA-I. OxHDL demonstrates altered anti-inflammatory properties, potentially becoming pro-inflammatory under certain conditions. The antioxidant capabilities of HDL, mediated by enzymes like paraoxonase-1, are compromised following oxidation.

Role in Cardiovascular Pathologies

OxHDL plays a role, in the development of disease and is particularly linked to atherosclerosis progression in the body’s arteries. In the wall lining OxHDL accumulation leads to dysfunction through various pathways such as heightened production of inflammatory mediators and decreased availability of nitric oxide. The presence of OxHDL encourages the recruitment and activation of cells which hastens the formation of plaques. Moreover, it impacts platelet function and blood clotting factors potentially increasing the risk of thrombosis. In individuals with metabolic syndrome levels of OxHDL are associated with the severity and complications of the condition indicating its significance, as both an indicator and influencer of metabolic irregularities.

Clinical Significance and Therapeutic Approaches

The significance of OxHDL, in settings goes beyond its impact from a health standpoint. There is a growing body of evidence suggesting its usefulness as a cardiovascular disease risk indicator possibly providing capabilities than the conventional HDL-C tests. Efforts are underway to devise treatments that target OxHDL ranging from measures against HDL oxidation to techniques for eliminating or neutralizing already oxidized components. Cutting edge therapeutic advancements are centred around reinforcing HDLs ability to withstand oxidation through modifications or, by enhancing its innate antioxidant mechanisms.

Many methods, for prevention focus on changing one’s lifestyle and taking antioxidant supplements to reduce the formation of OxHDL; however; more research is needed to confirm their effectiveness fully. New treatment methods involve creating HDL substances that are resistant to oxidation and developing compounds that can target and neutralize OxHDL specifically. Although these strategies look hopeful in studies, on animals or cells in a lab setting; more research is necessary before they can be used in practice effectively.

In the studies to come are delving deeper into comprehending how OxHDL links to disease conditions and exploring ways to enhance detection methods, with greater precision and sensitivity while pinpointing fresh targets for treatment strategies. In light of the nature of HDL oxidation and its impact, on biology it’s clear that a multi-faceted approach may be needed for treating cardiovascular issues effectively.

Suitable ELISA Kits

Online Enquiry Form

"*" indicates required fields

Please check mark information required:

TESTIMONIALS arrow icon

Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford